Recent insights into factors affecting remnant lipoprotein uptake
The DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Remnant lipoproteins that persist in the bloodstream after each meal have become increasingly important contributors to atherosclerotic vascular disease, owing to the spread of overnutrition, underexertion, obesity, insulin resistance, and type 2 diabetes. Here, we review recent work that clarified long-standing controversies over the molecular mediators of remnant clearance by the liver, as well as their dysregulation - but possible correction - during alterations in caloric balance. RECENT FINDINGS: Two endocytic receptors, the syndecan-1 heparan sulfate proteoglycan (HSPG) and the LDL receptor, plus one docking receptor, SR-BI, significantly contribute to normal hepatic remnant catabolism. Compelling evidence exists for dysfunction of the syndecan-1 HSPG in diabetic states. The major molecular defect identified so far in poorly controlled type 1 diabetes is impaired hepatic HSPG assembly. In contrast, the primary defect in hepatic HSPGs in type 2 diabetes appears to arise from accelerated de-sulfation, owing to the induction of a sulfatase. Moreover, short-term caloric restriction restores hepatic expression of this sulfatase towards normal. SUMMARY: Correct identification of hepatic remnant receptors has finally allowed investigations of their molecular dysregulation in diabetes and related conditions. New work points to novel therapeutic targets to correct postprandial dyslipoproteinemia and its consequent arterial damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“heparan sulfate proteoglycans in the liver space of Disse mediate clearance of triglyceride-rich lipoproteins independently of the well-known LDL receptor family members (954 -955).”
From Biological roles of glycans (2017) · cites this paper as [955]
In the citing paper
“Furthermore, an increased content of apoE in apoB containing lipoproteins may promote atherogenesis [62,63].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [62]
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Self-citationBiology of the Syndecans: A Family of Transmembrane Heparan Sulfate Proteoglycans
Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., Gallo, R. L., & Lose, E. J. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.002053 · Cited by 1,097
Dyslipidemia in type 2 diabetes mellitus
Mooradian, A. D. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1066 · Cited by 1,042
Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820
Kowal, R. C., Herz, J., Goldstein, J. L., Esser, V, & Brown, M. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5810 · Cited by 595
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.
Kane, J. P., Hardman, D. A., & Paulus, H. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2465 · Cited by 584
Nonfasting triglycerides and risk of ischemic stroke in the general population
Freiberg, J. J. (2008) · JAMA · doi:10.1001/jama.2008.621 · Cited by 542
Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1240 · Cited by 455
Cardiovascular Disease in the Developing World and Its Cost-Effective Management
Gaziano, T. A. (2005) · Circulation · doi:10.1161/circulationaha.105.591792 · Cited by 442
Integral membrane heparan sulfate proteoglycans
David, G. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.11.8370471 · Cited by 418
Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
Chen, M. H., Kerkelä, R., & Force, T. (2008) · Circulation · doi:10.1161/circulationaha.108.776831 · Cited by 379
Babitt, J., Trigatti, B., Rigotti, A., Smart, E. J., Anderson, R. W., Xu, S., & Krieger, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13242 · Cited by 376
Atherosclerosis: The low-density lipoprotein receptor hypothesis
Goldstein, J. L., & Brown, M. S. (1977) · Metabolism · doi:10.1016/0026-0495(77)90119-6 · Cited by 336
Schissel, S. L., Jiang, X.-C., Tweedie-Hardman, J., Jeong, T.-S., Camejo, E. H., Najib, J., Rapp, J. H., Williams, K. J., & Tabas, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2738 · Cited by 322
Self-citationConformation and dynamics of heparin and heparan sulfate
Mulloy, B., & Forster, M. J. (2000) · Glycobiology · doi:10.1093/glycob/10.11.1147 · Cited by 315
Glucose Regulates the Expression of the Farnesoid X Receptor in Liver
Duran-Sandoval, D., Mautino, G., Martin, G., Percevault, F., Barbier, O., Fruchart, J.-C., Kuipers, F., & Staels, B. (2004) · Diabetes · doi:10.2337/diabetes.53.4.890 · Cited by 257
Schneeman, B. O., Kotite, L., Todd, K. M., & Havel, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2069 · Cited by 255
Cohn, J. S., Johnson, E. J., Millar, J. S., Cohn, S. D., Milne, R. W., Marcel, Y. L., Russell, R. M., & Schaefer, E. J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35345-1 · Cited by 248
Hayashi, K., Hayashi, M., Jalkanen, M., Firestone, J. H., Trelstad, R. L., & Bernfield, M. (1987) · Journal of Histochemistry & Cytochemistry · doi:10.1177/35.10.2957423 · Cited by 247
Scott, J. E. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.050179 · Cited by 245
Stanford, K. I., Bishop, J. R., Foley, E. M., Gonzales, J. C., Niesman, I. R., Witztum, J. L., & Esko, J. D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38251 · Cited by 226
The syndecans, tuners of transmembrane signaling
Zimmermann, P., & David, G. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9001.s91 · Cited by 217
MacArthur, J. M., Bishop, J. R., Stanford, K. I., Wang, L., Bensadoun, A., Witztum, J. L., & Esko, J. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29154 · Cited by 216
Fuki, I. V., Kuhn, K. M., Lomazov, I. R., Rothman, V. L., Tuszynski, G. P., Iozzo, R. V., Swenson, T. L., Fisher, E. A., & Williams, K. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119685 · Cited by 213
Self-citationHussain, M. M., Maxfield, F. R., Más-Oliva, J., Tabas, I., Ji, Z. S., Innerarity, T. L., & Mahley, R. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92792-4 · Cited by 211
Lai, J., Sandhu, D. S., Yu, C., Han, T., Moser, C. D., Jackson, K. K., Guerrero, R. B., Aderca, I., Isomoto, H., Garrity‐Park, M. M., et al. (2008) · Hepatology · doi:10.1002/hep.22202 · Cited by 208
Williams, K. J., Fless, G. M., Petrie, K. A., Snyder, M. L., Brocia, R. W., & Swenson, T. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42208-9 · Cited by 205
Self-citationLiver heparan sulfate structure. A novel molecular design
Lyon, M., Deakin, J. A., & Gallagher, J. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78112-5 · Cited by 202
Kesaniemi, Y. A., Witztum, J. L., & Steinbrecher, U. P. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110849 · Cited by 202
Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis
Proctor, S. D., Vine, D. F., & Mamo, J. C. L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00001 · Cited by 201
Cohn, J. S., McNamara, J. R., Cohn, S. D., Ordovas, J. M., & Schaefer, E. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38485-6 · Cited by 195
Alterations in the Basement Membrane (Heparan Sulfate) Proteoglycan in Diabetic Mice
Rohrbach, D. H., Hassell, J. R., Kleinman, H. K., & Martin, G. R. (1982) · Diabetes · doi:10.2337/diab.31.2.185 · Cited by 183
Karpe, F., Boquist, S., Tang, R., Bond, G. M., de Faire, U., & Hamsten, A. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32331-2 · Cited by 174
Kita, T., Goldstein, J. L., Brown, M. S., Watanabe, Y., Hornick, C. A., & Havel, R. J. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3623 · Cited by 167
A focused microarray approach to functional glycomics: transcriptional regulation of the glycome
Comelli, E. M., Head, S. R., Gilmartin, T., Whisenant, T., Haslam, S. M., North, S. J., Wong, N.-K., Kudo, T., Narimatsu, H., Esko, J. D., et al. (2006) · Glycobiology · doi:10.1093/glycob/cwj048 · Cited by 167
Bradley, W. A., Hwang, S. L., Karlin, J. B., Lin, A. H., Prasad, S. C., Gotto, A. M., & Gianturco, S. H. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42663-9 · Cited by 166
Rensen, P. C., Herijgers, N., Netscher, M. H., Meskers, S. C., van Eck, M., & van Berkel, T. J. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37190-x · Cited by 164
Molecular processes that handle — and mishandle — dietary lipids
Williams, K. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35206 · Cited by 160
Self-citationSchaefer, E. J., McNamara, J. R., Tayler, T., Daly, J. A., Gleason, J. L., SEMAN, L. J., Ferrari, A., & Rubenstein, J. J. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.008 · Cited by 157
Cohn, J. S., Marcoux, C., & Davignon, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2474 · Cited by 156
Lamanna, W. C., Frese, M., Balleininger, M., & Dierks, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802130200 · Cited by 155
Abidi, P., Zhou, Y., Jiang, J.-D., & Liu, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000181761.16341.2b · Cited by 152
FUKI, I. V., MEYER, M. E., & WILLIAMS, K. J. (2000) · Biochemical Journal · doi:10.1042/bj3510607 · Cited by 151
Self-citationRoerdink, F. H., DIJKSTRA, J., HARTMAN, G. C., Bolscher, B. G. J. M., & Scherphof, G. L. (1981) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(81)90148-3 · Cited by 149
Drosophila syndecan: conservation of a cell-surface heparan sulfate proteoglycan.
Spring, J., Paine-Saunders, S. E., Hynes, R. O., & Bernfield, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3334 · Cited by 148
Karpe, F., Bell, M., Björkegren, J., & Hamsten, A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.199 · Cited by 143
Tkachenko, E., Lutgens, E., Stan, R.-V., & Simons, M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01190 · Cited by 141
Hiukka, A., Ståhlman, M., Pettersson, C., Levin, M., Adiels, M., Teneberg, S., Leinonen, E. S., Hultén, L. M., Wiklund, O., Orešič, M., et al. (2009) · Diabetes · doi:10.2337/db09-0206 · Cited by 141
Ji, Z. S., Fazio, S., & Mahley, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36849-7 · Cited by 138
Felts, J. M., Itakura, H., & Thomas Crane, R. (1975) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(75)90524-0 · Cited by 137
Brown Adipose Tissue — When It Pays to Be Inefficient
Celi, F. S. (2009) · New England Journal of Medicine · doi:10.1056/nejme0900466 · Cited by 137
A treasure trove for lipoprotein biology
Lusis, A. J., & Pajukanta, P. (2008) · Nature Genetics · doi:10.1038/ng0208-129 · Cited by 133
Lipoprotein Retention—and Clues for Atheroma Regression
Williams, K. J., & Tabas, I. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000174795.62387.d3 · Cited by 131
Self-citationHogue, J.-C., Lamarche, B., Tremblay, A. J., Bergeron, J., Gagné, C., & Couture, P. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600548-jlr200 · Cited by 129
Atherosclerosis and Alimentary Hyperlipemia
Moreton, J. R. (1947) · Science · doi:10.1126/science.106.2748.190 · Cited by 123
Metabolic heterogeneity of apolipoprotein B in the rat
Sparks, C. E., & Marsh, J. B. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34967-1 · Cited by 119
Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism
Jon Williams, K., & Fuki, I. V. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00003 · Cited by 113
Self-citationPostprandial lipoprotein metabolism and atherosclerosis
Karpe, F., & Hamsten, A. (1995) · Current Opinion in Lipidology · doi:10.1097/00041433-199506000-00003 · Cited by 112
Kotzka, J., Lehr, S., Roth, G., Avci, H., Knebel, B., & Muller-Wieland, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401198200 · Cited by 111
Electrophysiological Challenges of Cell-Based Myocardial Repair
Chen, H.-S. V., Kim, C., & Mercola, M. (2009) · Circulation · doi:10.1161/circulationaha.107.751412 · Cited by 111
Laatsch, A., Merkel, M., Talmud, P. J., Grewal, T., Beisiegel†, U., & Heeren, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.046 · Cited by 111
Identification of the Proteoglycan Binding Site in Apolipoprotein B48
Flood, C., Gustafsson, M., Richardson, P. E., Harvey, S. C., Segrest, J. P., & Borén, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204053200 · Cited by 108
Heparan sulfate proteoglycan expression in normal human liver
Roskams, T., Moshage, H., de Vos, R., Guido, D., Yap, P., & Desmet, V. (1995) · Hepatology · doi:10.1002/hep.1840210410 · Cited by 107
Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo
Eck, M. V., Hoekstra, M., Out, R., Bos, I. S. T., Kruijt, J. K., Hildebrand, R. B., & van Berkel, T. J. C. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700355-jlr200 · Cited by 106
Role of the Low Density Lipoprotein (LDL) Receptor Pathway in the Metabolism of Chylomicron Remnants
Ishibashi, S., Perrey, S., Chen, Z., Osuga, J.-I., Shimada, M., Ohashi, K., Harada, K., Yazaki, Y., & Yamada, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22422 · Cited by 106
Apolipoprotein A-V Interaction with Members of the Low Density Lipoprotein Receptor Gene Family
Nilsson, S. K., Lookene, A., Beckstead, J. A., Gliemann, J., Ryan, R. O., & Olivecrona, G. (2007) · Biochemistry · doi:10.1021/bi7000533 · Cited by 102
Rubinsztein, D. C., Cohen, J. C., Berger, G. M., van der Westhuyzen, D. R., Coetzee, G. A., & Gevers, W. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114839 · Cited by 101
Véniant, M. M., Pierotti, V, Newland, D., Cham, C. M., Sanan, D. A., Walzem, R. L., & Young, S. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119511 · Cited by 100
Herz, J., Qiu, S. Q., Oesterle, A., DeSilva, H. V., Shafi, S., & Havel, R. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4611 · Cited by 98
Chunyu, Z., Christina, K., Katsunori, I., & Sacks, F. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.p600011-jlr200 · Cited by 95
Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice
Han, S., Liang, C.-P., Westerterp, M., Senokuchi, T., Welch, C. L., Wang, Q., Matsumoto, M., Accili, D., & Tall, A. R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36523 · Cited by 94
Scavenger Receptor BI Plays a Role in Facilitating Chylomicron Metabolism
Out, R., Kruijt, J. K., Rensen, P. C. N., Hildebrand, R. B., de Vos, P., Van Eck, M., & Van Berkel, T. J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401170200 · Cited by 90
Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X Receptor
Anisfeld, A. M., Kast-Woelbern, H. R., Meyer, M. E., Jones, S. A., Zhang, Y., Williams, K. J., Willson, T., & Edwards, P. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302505200 · Cited by 88
Self-citationStructure and Dynamics of Human Apolipoprotein CIII
Gangabadage, C. S., Zdunek, J., Tessari, M., Nilsson, S., Olivecrona, G., & Wijmenga, S. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800756200 · Cited by 88
Sensing of Dietary Lipids by Enterocytes: A New Role for SR-BI/CLA-1
Béaslas, O., Cueille, C., Delers, F., Château, D., Chambaz, J., Rousset, M., & Carrière, V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004278 · Cited by 87
Ebara, T., Conde, K., Kako, Y., Liu, Y., Xu, Y., Ramakrishnan, R., Goldberg, I. J., & Shachter, N. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8283 · Cited by 86
Heparan Sulfate 2-O-Sulfotransferase Is Required for Triglyceride-rich Lipoprotein Clearance
Stanford, K. I., Wang, L., Castagnola, J., Song, D., Bishop, J. R., Brown, J. R., Lawrence, R., Bai, X., Habuchi, H., Tanaka, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063701 · Cited by 84
Psychosocial factors impair vascular responses of coronary arteries.
Williams, J. K., Vita, J. A., Manuck, S. B., Selwyn, A. P., & Kaplan, J. R. (1991) · Circulation · doi:10.1161/01.cir.84.5.2146 · Cited by 82
Grobe, K., & Esko, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111904200 · Cited by 81
Mokuno, H., Brady, S., Kotite, L., Herz, J., & Havel, R. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36824-2 · Cited by 77
Tabas, I., Myers, J. N., Innerarity, T. L., Xu, X. X., Arnold, K., Boyles, J., & Maxfield, F. R. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.6.1547 · Cited by 77
Mortimer, B.-C., Beveridge, D. J., Martins, I. J., & Redgrave, T. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28767 · Cited by 74
Burgos, P. V., Klattenhoff, C., de la Fuente, E., Rigotti, A., & González, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400295101 · Cited by 73
Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease
López-Miranda, J., Pérez-Martínez, P., Marín, C., Moreno, J. A., Gómez, P., & Pérez-Jiménez, F. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000217894.85370.c2 · Cited by 72
Arito, M., Horiba, T., Hachimura, S., Inoue, J., & Sato, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800910200 · Cited by 72
Chylomicronemia elicits atherosclerosis in mice—brief report.
Weinstein, M. M., Yin, L., Tu, Y., Wang, X., Wu, X., Castellani, L. W., Walzem, R. L., Lusis, A. J., Fong, L. G., Beigneux, A. P., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.196329 · Cited by 71
Björkegren, J., Boquist, S., Samnegård, A., Lundman, P., Tornvall, P., Ericsson, C.-G., & Hamsten, A. (2000) · Circulation · doi:10.1161/01.cir.101.3.227 · Cited by 70
Reduced Sulfation of Liver Heparan Sulfate in Experimentally Diabetic Rats
Kjellén, L., Bielefeld, D., & Hook, M. (1983) · Diabetes · doi:10.2337/diab.32.4.337 · Cited by 67
Atorvastatin Improves Postprandial Lipoprotein Metabolism in Normolipidemic Subjects1
Parhofer, K. G., Barrett, P. H. R., & Schwandt, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6978 · Cited by 65
Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders
Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000199815.46720.ca · Cited by 64
Glucosaminyl N-deacetylase/N-sulphotransferases in heparan sulphate biosynthesis and biology.
Kjellén, L. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310340 · Cited by 60
Wilsie, L. C., Gonzales, A. M., & Orlando, R. A. (2006) · Lipids in Health and Disease · doi:10.1186/1476-511x-5-23 · Cited by 60
McCollum Award Lecture, 1992: Vitamin A absorption, transport, cellular uptake, and storage
Norum, K., & Blomhoff, R. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.4.735 · Cited by 60
Diabetes alters LDL receptor and PCSK9 expression in rat liver
Niesen, M. I., Bedi, M., & Lopez, D. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.11.009 · Cited by 58
Zambon, A., Deeb, S. S., Bensadoun, A., Foster, K. E., & Brunzell, J. D. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32372-5 · Cited by 57
Ledin, J., Ringvall, M., Thuveson, M., Eriksson, I., Wilén, M., Kusche-Gullberg, M., Forsberg, E., & Kjellén, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604113200 · Cited by 55
Rodrigueza, W. V., Mazany, K. D., Essenburg, A. D., Pape, M. E., Rea, T. J., Bisgaier, C. L., & Williams, K. J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2132 · Cited by 53
Self-citationOut, R., Hoekstra, M., de Jager, S. C. A., de Vos, P., van der Westhuyzen, D. R., Webb, N. R., Van Eck, M., Biessen, E. A. L., & Van Berkel, T. J. C. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400361-jlr200 · Cited by 52
Goldberg, I. J., Hu, Y., Noh, H. L., Wei, J. C., Huggins, L. A., Rackmill, M. G., Hamai, H., Reid, B. N., Blaner, W. S., & Huang, L. (2008) · Diabetes · doi:10.2337/db08-0083 · Cited by 52
Shetty, S., Eckhardt, E. R. M., Post, S. R., & van der Westhuyzen, D. R. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000233335.26362.37 · Cited by 51
Hansen, G. H., Niels-Christiansen, L.-L., Immerdal, L., & Danielsen, E. M. (2003) · Gut · doi:10.1136/gut.52.10.1424 · Cited by 49
Zheng, C., Murdoch, S. J., Brunzell, J. D., & Sacks, F. M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000203512.01007.3d · Cited by 48
Fu, T., Kozarsky, K., & Borensztajn, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310892200 · Cited by 47
Distinct Hepatic Receptors for Low Density Lipoprotein and Apolipoprotein E in Humans
Hoeg, J. M., Demosky, S. J., Gregg, R. E., Schaefer, E. J., & Brewer, H. B. (1985) · Science · doi:10.1126/science.2982214 · Cited by 45
Chan, D. C., Watts, G. F., Barrett, P. H. R., Martins, I. J., James, A. P., Mamo, J. C. L., Mori, T. A., & Redgrave, T. G. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30112-7 · Cited by 44
Olsson, U., Egnell, A.-C., Lee, M. R., Lundén, G. O., Lorentzon, M., Salmivirta, M., Bondjers, G., & Camejo, G. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2126 · Cited by 44
Dane‐Stewart, C. A., Watts, G. F., Barrett, P. H. R., Stuckey, B. G. A., Mamo, J. C. L., Martins, I. J., & Redgrave, T. G. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01731.x · Cited by 42
The ins (cell) and outs (plasma) of apolipoprotein A-V
Forte, T. M., Shu, X., & Ryan, R. O. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800050-jlr200 · Cited by 38
Mann, W. A., Meyer, N., Weber, W., Meyer, S., Greten, H., & Beisiegel, U. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39885-0 · Cited by 37
Measuring the Activities of the Sulfs: Two Novel Heparin/Heparan Sulfate Endosulfatases
Uchimura, K., Morimoto‐Tomita, M., & Rosen, S. D. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)16015-2 · Cited by 36
Windler, E., Greeve, J., Robenek, H., Rinninger, F., Greten, H., & Jäckle, S. (1996) · Hepatology · doi:10.1002/hep.510240210 · Cited by 35
Inaba, T., Ishibashi, S., Harada, K., Ohsuga, J.-I., Ohashi, K., Yagyu, H., Yazaki, Y., Higashiyama, S., Kawata, S., Matsuzawa, Y., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24413 · Cited by 35
Loss of Heparan N-Sulfotransferase in Diabetic Liver
Williams, K. J., Liu, M.-L., Zhu, Y., Xu, X., Davidson, W. R., McCue, P., & Sharma, K. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1116 · Cited by 31
Self-citationKaralis, D. G., Ishisaka, D. Y., Luo, D., Ntanios, F. Y., & Wun, C. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.043 · Cited by 30
Activation of ERK signaling upon alternative protease nexin‐1 internalization mediated by syndecan‐1
Li, X., Herz, J., & Monard, D. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20881 · Cited by 30
Georgopoulos, A. P., & Phair, R. D. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41976-5 · Cited by 28
Dane-Stewart, C. A., Watts, G. F., Pal, S., Chan, D. C., Thompson, P. L., Hung, J., & Mamo, J. C. L. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00281-6 · Cited by 28
Pieters, M. N., Esbach, S., Schouten, D., Brouwer, A., Knook, D. L., & van Berkel, T. J. C. (1994) · Hepatology · doi:10.1002/hep.1840190622 · Cited by 27
Boquist, S., Karpe, F., Danell-Toverud, K., & Hamsten, A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00689-x · Cited by 25
Dichek, H. L., Qian, K., & Agrawal, N. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300459-jlr200 · Cited by 23
Nader, H. B., Ferreira, T. M. P. C., Toma, L., Chavante, S. F., Dietrich, C. P., Casu, B., & Torri, G. (1988) · Carbohydrate Research · doi:10.1016/0008-6215(88)80034-x · Cited by 20
Milliat, F., Gripois, D., Blouquit, M.-F., Férézou, J., Sérougne, C., Fidge, N., & Lutton, C. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-8401 · Cited by 20
Webb, N. R., de Beer, M. C., de Beer, F. C., & van der Westhuyzen, D. R. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300319-jlr200 · Cited by 19
Martins, I. J., Tran, J., & Redgrave, T. G. (2002) · Journal of Nutrition · doi:10.1093/jn/132.2.176 · Cited by 18
Interactions of Lipoproteins with Proteoglycans
Williams, K. J. (2003) · Proteoglycan Protocols · doi:10.1385/1-59259-209-0:457 · Cited by 17
Self-citationYbarra, J., James, R. W., Makoundou, V., Bioletto, S., & Golay, A. (2001) · PubMed · Cited by 14
Chen, K., Liu, M.-L., Schäffer, L., Li, M., & Williams, K. (2009) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(09)70280-6 · Cited by 3
Self-citationParthasarathy, N., Goldberg, I. J., Pillarisetti, S., & Wagner, W. D. (1996) · Journal of Biochemical and Biophysical Methods · doi:10.1016/0165-022x(95)00045-s · Cited by 2
Research works printed but not linked: 8
- Parhofer, 2000, J Clin Endocrinol Metab, 85, 4224
- Williams, 2001, Methods Mol Biol, 171, 457
- Stanford, 2009, J Clin Invest, 119, 3236
- Han, 2009, J Clin Invest, 119, 1029
- Murao, 2007, Am J Physiol, 294, E78
- Ybarra, 2001, Diabetes Metab, 27, 701
- Mooradian, 2009, Nat Clin Pract Endocrinol Metab, 5, 150
- Liu, 2004, Arterioscler Thromb Vasc Biol, 24, E
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“For example heparan sulfate proteoglycans in the liver space of Disse mediate clearance of triglyceride-rich lipoproteins independently of the well-known LDL receptor family members (954, 955).”
BackgroundLipid Nanoparticle Systems for Enabling Gene Therapies
Cullis, P. R., & Hope, M. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.013 · Cited by 1,208
“These results suggest that LNP siRNA systems containing ionizable cationic lipids are processed much like chylomicrons, which adsorb endogenous ApoE to trigger uptake into hepatocytes via several receptors that contain ApoE binding ligands.(24)”
BackgroundBorén, J., & Williams, K. J. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000330 · Cited by 524
Self-citationNew insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440
“The importance of the HSPG pathway has been questioned, but recent results demonstrate that dysfunction of syndecan-1 in animal models disrupts defective hepatic remnant clearance [222].”
BackgroundRecent advances in physiological lipoprotein metabolism
Ramasamy, I. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0358 · Cited by 235
“The syndecan-1 HSPG has been suggested as a major HSPG receptor for remnant lipoproteins in the liver [84].”
Background
Metadata
- Authors
- Williams, K. J., & Chen, K.
- Affiliations
- Temple University (US)
- Corresponding author
- Williams, Kevin Jon
- Venue
- Current Opinion in Lipidology
- Published
- 2010-06
- Volume
- 21
- Issue
- 3
- Pages
- 218-228
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W1966190991
- Cited by
- 91
- References
- 135
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 2 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 12 · 2015: 10 · 2014: 4 · 2013: 11 · 2012: 12
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 38956, R01HL094277, R01HL073898, HL73898, HL94277)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK043396)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- remnant lipoproteins, syndecan-1, heparan sulfate proteoglycans, LDL receptor, scavenger receptor class B type I, type 2 diabetes, type 1 diabetes, sulfatase, caloric restriction, atherosclerosis, energy balance
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Diabetes Mellitus, Humans, Lipoproteins, Liver, Molecular Sequence Data, Receptors, LDL, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.